Paradigm
PrivateLast Round
Series B
Dec 4, 2025
Total Funding Raised
$281M
Momentum Score
25 /100
Company Overview
Paradigm (Drug Discovery) is a health technology company that offers a platform designed to optimize the clinical trial process by connecting biopharmaceutical sponsors with healthcare providers, thereby improving trial efficiency and accelerating access to life-saving therapies for patients.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Vertical SaaS, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradigm Comps
Public and private peers based on sector, stage, and business model.
Paradigm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 4, 2025 | ||||
| Series A | Jan 25, 2023 |
Key People
Founding team and executive leadership
Paradigm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series A, Series B |
| ARCH Venture Partners | Series B |
| F-Prime Capital | Series A, Series B |
| Magnetic Ventures | Series A |
| BrightEdge | Series B, Series A |
| Lux Capital | Series A, Series B |
| ARCH Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Partnered with the U.S. Food and Drug Administration to test a new data system.
- Dec 4, 2025
$78M Series B round completed.
Paradigm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paradigm's valuation, stock price, and market status.
